The ASE announces that PHILADELPHIA PHARMACEUTICALS (PHIL) has completed all required procedures to increase its listed capital from JD/Share 5 million to JD/Share 7.5 million through stock dividends.
Accordingly, the ASE will list the new shares on Monday May 30th 2016 with a reference price of JD3.10 .